Description

Gazyva is a monoclonal antibody used in the treatment of certain types of blood cancers, including chronic lymphocytic leukemia (CLL). It works by targeting and destroying specific cancer cells, helping to improve patient outcomes.

Interpreter Notes

Interpreters should be aware that Gazyva may be referred to by its generic name, obinutuzumab, in some contexts. It is important to maintain a formal and clinical register when discussing this medication. Avoid colloquial terms and ensure clarity to prevent confusion with other cancer treatments.

Example Sentences

EN: The oncologist prescribed Gazyva as part of the patient's treatment plan for chronic lymphocytic leukemia.

ES: El oncólogo recetó Gazyva como parte del plan de tratamiento del paciente para la leucemia linfocítica crónica.

Common Interpreter Mistakes

Confusing Gazyva with other cancer medications; mispronouncing Gazyva as if it were a common Spanish word; using informal language when discussing the medication.